Award
Delivery Order #SPE2DR26F3Q4J
AmerisourceBergen Delivery Order for ENVARSUS XR Tablets
Buyer
Defense Logistics Agency
Award Amount
$1,858.42
Ceiling
$1,858.42
Awarded
March 06, 2026
Period of Performance
Mar 06, 2026 – Mar 27, 2026
Identifier
SPE2DR26F3Q4J
NAICS
424210
This award represents a delivery order contract under a broader indefinite delivery vehicle (IDV) established for pharmaceutical supplies. The recipient, AmerisourceBergen Drug Corp, is a prominent pharmaceutical distribution company that plays a vital role in delivering essential medications across healthcare sectors. The contract focuses on procuring ENVARSUS XR 4 MG tablets, a specific pharmaceutical product required to support patient treatment regimens. This delivery order is significant as it ensures timely and reliable access to critical medication, thereby supporting healthcare providers' efforts to maintain high standards of patient care. The scope of work includes the supply and delivery of the specified tablets within a short performance window. This award is a continuation of the strategic partnership under the existing IDV pharmaceutical contract with AmerisourceBergen. The contract was competitively awarded within this existing agreement framework, emphasizing efficient and prompt pharmaceutical procurement. The performance timeline for this delivery order spans a brief period in early 2026, reflecting a targeted and immediate supply need.
Description
4571062244!ENVARSUS XR 4 MG TABLET 100S